Global Cervical Cancer Diagnostic Testing Market to 2023 - Market will Register a CAGR of More than 6%

News provided by

Nov 21, 2018, 10:45 ET

DUBLIN, Nov 21, 2018 /PRNewswire/ --

The "Global Cervical Cancer Diagnostic Testing Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The cervical cancer diagnostic testing market will register a CAGR of more than 6% by 2023

With the growth in geriatric population worldwide, the increasing age plays a significant prognostic role in the development of cervical cancer. According to the US Census Bureau, the global geriatric population (65 years and above) is expected to exceed 1.5 billion by 2050, making it approximately 16% of the total world's population.

Market Overview

Increased adoption of HPV home testing kits

Several large companies are focused on R&D of new and innovative products that can provide accurate and instant test results at home and cut down cost burden on the patients on management of cervical cancer. In addition, the rising awareness on the importance of cervical cancer screen on time will fuel the demand for cervical cancer diagnostic market during the next five years.

Varying screening policies

The recommended screening policies for cervical cancer usually vary in different countries. Although certain professional societies and organizations have developed guidelines, efforts are needed for their uniform implementation. The difference in the target age can lead to shortcomings in terms of routine registration for the screening program, evaluation, and monitoring, which can negatively impact the adoption of cervical cancer diagnostic testing.

Competitive Landscape

The market appears to be quite fragmented but will become highly concentrated with the presence of a few companies including Abbott Laboratories and BD, the competitive environment is very intense. Factors such as the growth in geriatric population and increased adoption of HPV home testing kits, will provide considerable growth opportunities to cervical cancer diagnostic testing vendors. Abbott Laboratories, BD, F. Hoffmann-La Roche, Hologic, and QIAGEN are some of the major companies covered in this report.

Report Summary:

One trend affecting this market is the growth in geriatric women population. The increasing age plays a significant prognostic role in the development of cervical cancer. Globally, the population or elderly women is increasing.

According to the report, one driver influencing this market is the increased adoption of HPV home testing kits. Leading vendors have developed innovative home-based products that provide quick and accurate test results which helps in reducing costs for patients and management of cervical cancer.

Further, the report states that one challenge affecting this market is the varying screening policies. The recommended screening policies for cervical cancer usually vary in different countries. Although certain professional societies and organizations have developed guidelines, efforts are needed for their uniform implementation, which poses a challenge for the growth of the market.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis

PART 04: MARKET SIZING

Market definition
Market sizing 2018
Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

PART 06: MARKET SEGMENTATION BY END-USER

PART 07: MARKET SEGMENTATION BY TYPE

Market segmentation by type
Comparison by type
Pap smear test - Market size and forecast 2018-2023
HPV testing - Market size and forecast 2018-2023
Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TECHNOLOGY

PART 10: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
Americas - Market size and forecast 2018-2023
EMEA - Market size and forecast 2018-2023
APAC - Market size and forecast 2018-2023
Key leading countries
Market opportunity

PART 11: MARKET SEGMENTATION BY METHOD

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

Market drivers
Market challenges

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

Overview
Landscape disruption

PART 16: VENDOR ANALYSIS

Vendors covered
Vendor classification
Market positioning of vendors
Abbott Laboratories
BD
F. Hoffmann-La Roche
Hologic
QIAGEN

PART 17: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/3wkp4d/global_cervical?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets